Skip to main content

Day: June 1, 2023

Parsons to Present at the Stifel 2023 Cross Sector Insight Conference

CENTREVILLE, Va., June 01, 2023 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) will present at Stifel 2023 Cross Sector Insight Conference. Carey Smith, chair, president, and chief executive officer, will participate in a fireside chat question and answer session on Tuesday, June 6, 2023, at approximately 2:25 p.m. Eastern Time. This presentation will be available live via webcast on the investor relations section of Parsons’ website (https://investors.parsons.com/). A replay of the webcast also will be available on the website for 30 days. About ParsonsParsons (NYSE: PSN) is a leading disruptive technology provider in the national security and global infrastructure markets, with capabilities across cyber and intelligence, space and missile defense, transportation, environmental remediation, urban development, and critical...

Continue reading

New Employee Representative for the Board of Directors at The BANK of Greenland

  To Nasdaq OMX Copenhagen01 June 2023Company announcement no. 10/2023 New Employee Representative for the Board of Directors at The BANK of Greenland As of today, employee representative Vitta Motzfeldt, has chosen to resign from the Board of Directors at her own request. At the election of employee representatives in 2023, Tulliaq Olsen was elected as 1. suppleant and he therefore enters into the Board of Directors as employee representative as of today’s date. Please direct any queries to: The Bank of GreenlandMartin KviesgaardManaging Director Telephone: +299 34 78 02E-mail: mbk@banken.glAttachment10.Ny medarbejderrepræsentant i bestyrelsen 01062023_UK

Continue reading

Solaris Reports Highest Grades to Date in Second Porphyry Centre Outside Resource at Warintza East, with 301m of 0.65% CuEq from Surface Ending in 31m of 0.76% CuEq

Figure 1 – Plan View of Warintza East Drilling Released to Date Figure 1 – Plan View of Warintza East Drilling Released to DateVANCOUVER, British Columbia, June 01, 2023 (GLOBE NEWSWIRE) — Solaris Resources Inc. (TSX: SLS; OTCQB: SLSSF) (“Solaris” or the “Company”) is pleased to announce assay results confirming the discovery of a second porphyry center featuring the highest grades to date at Warintza East, with strong mineralization starting from bedrock surface extending to the end of the hole. The new zone is open to the east, west, south and at depth, with follow-up drilling already underway at this important new discovery at the Warintza Project (“Warintza” or “the Project”) in southeastern Ecuador. Highlights are listed below, with a corresponding image in Figure 1 and results in Tables 1-2. HighlightsWarintza East was...

Continue reading

Lifecore Biomedical Reports Third Quarter Fiscal Year 2023 Results

Going concern qualification is removed as a result of the $150 million new financing transaction announced last week CHASKA, Minn., June 01, 2023 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), reported results for the fiscal 2023 third quarter ended February 26, 2023. CEO COMMENTS: James G. Hall, President and Chief Executive Officer of Lifecore, commented, “We took a noteworthy step forward last week with the execution of an enhanced Supply Agreement with a significant, long-term customer, Alcon, as well as completing a comprehensive restructuring of our debt arrangements led by Alcon. These transactions allow the Company to clear the existing Going Concern qualification and create a more stable and sustainable business...

Continue reading

Voyager Therapeutics to Present at the Jefferies Healthcare Conference

CAMBRIDGE, Mass., June 01, 2023 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced that CEO Alfred W. Sandrock, Jr., M.D., Ph.D., will present at the Jefferies Healthcare Conference on Thursday, June 8, 2023, at 3:30 p.m. ET. A webcast of the presentation may be accessed from the Investors section of Voyager’s website at www.voyagertherapeutics.com. A replay of the webcast will be archived on the Company’s website for at least 30 days. About Voyager TherapeuticsVoyager Therapeutics (Nasdaq: VYGR) is a biotechnology company dedicated to breaking through barriers in gene therapy and neurology. The potential of both disciplines has been constrained by delivery challenges; Voyager is leveraging cutting-edge...

Continue reading

TScan Therapeutics to Participate in the Jefferies Healthcare Conference

WALTHAM, Mass., June 01, 2023 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell therapies (TCR-T) for the treatment of patients with cancer, today announced that the Company will participate in a fireside chat at the Jefferies Healthcare Conference being held at the Marriott Marquis in New York, NY on Thursday, June 8, 2023 at 8:00 a.m. Eastern Time. A webcast of the fireside chat will be available on the “Events and Presentations” section of the Company’s website at ir.tscan.com. An archived replay of the webcast will be available on the Company’s website for 90 days following the event. About TScan Therapeutics, Inc. TScan is a clinical-stage biopharmaceutical company focused on the development of T cell...

Continue reading

Kymera Therapeutics to Participate in Upcoming June Investor Conference

WATERTOWN, Mass., June 01, 2023 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today announced that the Company’s management team will attend the following upcoming investor event:Goldman Sachs 44th Annual Global Healthcare Conference in Dana Point, CA on June 14 at 3:20 p.m. PT (6:20 p.m. ET)A live webcast of the fireside chat will be available under the “Events and Presentations” section of the Investors page on the Company’s website at www.kymeratx.com. A replay of the webcast will be archived and available following the event. About Kymera Therapeutics Kymera is a biopharmaceutical company pioneering the field of targeted protein degradation, a transformative...

Continue reading

atai Life Sciences to Participate in Upcoming June Investor Conferences

NEW YORK and BERLIN, June 01, 2023 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in upcoming June Investor Conferences. Details of the company’s participation are as follows:Jefferies 2023 Healthcare Conference Format: Corporate Presentation Date and Time: Friday, June 9th, 9:00 a.m. ET Location: New York, NY H.C. Wainwright 4th Annual Neuropsychiatry Virtual Conference Format: Corporate Presentation (“on-demand”) Date and Time: Monday, June 26th Location: Virtual A webcast will be available on atai’s website under Events on the Investors section of the atai website: https://ir.atai.life/news-events/events/. An archived replay of the webcast will be available for up to 30 days. About...

Continue reading

Lands’ End Announces First Quarter Fiscal 2023 Results

Net Revenue grew 1.9% compared to the same period last yearNet Loss of $1.7 million, compared to a Net loss of $2.4 million in the same period last yearAdjusted EBITDA increased by 41.3%, or $5.7 million, to $19.5 million compared to the same period last yearRaises Fiscal 2023 Outlook DODGEVILLE, Wis., June 01, 2023 (GLOBE NEWSWIRE) —  Lands’ End, Inc. (NASDAQ: LE) today announced financial results for the first quarter ended April 28, 2023. Andrew McLean, Chief Executive Officer, stated, “Our team continued to successfully execute during the quarter and made strong progress against our strategic initiatives. As a result, we delivered year-over-year revenue and earnings growth, led primarily by our leading swim business and its natural vacation adjacencies, which collectively contributed to our strong margin performance and our...

Continue reading

Duluth Holdings Inc. Announces First Quarter 2023 Financial Results

Garden, Landscaping and Planting Assortment By Duluth Trading Company Garden, Landscaping and Planting Assortment By Duluth Trading CompanyAKHG By Duluth Trading Company AKHG By Duluth Trading CompanyNet Sales increase year-over-year to $123.8 million fueled by AKHG sub-brand and Women’s business growth EBITDA of $4.3 million; Adjusted EBITDA of $5.3 million Strong financial condition with $210 million of liquidity Reaffirmed Fiscal 2023 outlook MOUNT HOREB, Wis., June 01, 2023 (GLOBE NEWSWIRE) — Duluth Holdings Inc. (dba, Duluth Trading Company) (“Duluth Trading” or the “Company”) (NASDAQ: DLTH), a lifestyle brand of men’s and women’s workwear, casual wear, outdoor apparel and accessories, today announced its financial results for the fiscal first quarter ended April 30, 2023. Highlights for the First Quarter Ended April...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.